We are live on ! Find out more
DA

DCF Advisers Portfolio holdings

AUM $375M
1-Year Est. Return 72.65%
This Fund
S&P 500
This Quarter Est. Return
+30.38%
1 Year Est. Return
+72.65%
3 Year Est. Return
+156.29%
5 Year Est. Return
+218.72%
10 Year Est. Return
–
AUM
$179M
AUM Growth
+$25.8M
Cap. Flow
-$11.5M
Cap. Flow %
-6.46%
Top 10 Hldgs %
49.87%
Holding
82
New
15
Increased
17
Reduced
25
Closed
12

Top Buys

Rank Stock Value
1
XNCR icon
Xencor
XNCR
+$3.26M
2
ESPR
Esperion Therapeutics
ESPR
+$1.11M
3
VZ icon
Verizon
VZ
+$984K
4
GLD icon
SPDR Gold Trust
GLD
+$806K
5
TGT icon
Target
TGT
+$571K

Top Sells

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$1.14M
2
XYZ
Block Inc
XYZ
+$1.05M
3
GDX icon
VanEck Gold Miners ETF
GDX
+$740K
4
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$639K
5
GM icon
General Motors
GM
+$623K

Sector Composition

Rank Sector Weight
1 Healthcare 37.61%
2 Technology 13.76%
3 Communication Services 9.15%
4 Financials 5.23%
5 Consumer Discretionary 1.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TGT icon
51
Target
TGT
$65.6B
$600K 0.34%
+5,000
New +$571K
ORCL icon
52
PUT
Oracle
ORCL
$374B
$553K 0.31%
+10,000
New +$530K
WBA
53
DELISTED
Walgreens Boots Alliance
WBA
$530K 0.3%
12,500
-3,000
-19% -$127K
MSFT icon
54
Microsoft
MSFT
$3.45T
$509K 0.28%
2,500
– –
CSCO icon
55
CALL
Cisco
CSCO
$457B
$466K 0.26%
+10,000
New +$439K
QCOM icon
56
Qualcomm
QCOM
$155B
$456K 0.26%
5,000
– –
TBHC
57
DELISTED
The Brand House Collective
TBHC
$446K 0.25%
164,693
+16,500
+11% +$20.4K
APTX
58
DELISTED
Aptinyx Inc. Common Stock
APTX
$445K 0.25%
106,800
+1,000
+0.9% +$3.38K
MTNB icon
59
Matinas BioPharma
MTNB
$1.88M
$436K 0.24%
11,276
-1,124
-9% -$43.1K
GMAB icon
60
Genmab
GMAB
$17.7B
$424K 0.24%
+12,500
New +$341K
NXPI icon
61
NXP Semiconductors
NXPI
$57.8B
$399K 0.22%
3,500
– –
KYNB
62
Kyntra Bio
KYNB
$27.2M
$385K 0.22%
380
-160
-30% -$149K
NOK icon
63
CALL
Nokia
NOK
$51B
$381K 0.21%
86,500
– –
VIR icon
64
Vir Biotechnology
VIR
$1.46B
$307K 0.17%
+7,500
New +$252K
ITCI
65
CALL
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$257K 0.14%
+10,000
New +$202K
TPB icon
66
Turning Point Brands
TPB
$1.45B
$243K 0.14%
+9,750
New +$224K
KSS icon
67
CALL
Kohl's
KSS
$2.17B
$208K 0.12%
+10,000
New +$193K
ACGN
68
DELISTED
Aceragen Inc
ACGN
$192K 0.11%
6,311
– –
ET icon
69
Energy Transfer Partners
ET
$70.1B
$122K 0.07%
17,200
+1,700
+11% +$12.6K
ADMS
70
DELISTED
Adamas Pharmaceuticals
ADMS
$80K 0.04%
31,236
-4,613
-13% -$13.6K
ADBE icon
71
Adobe
ADBE
$99.5B
– –
-1,000
Closed -$318K
BGY icon
72
BlackRock Enhanced International Dividend Trust
BGY
$524M
– –
-12,000
Closed -$54K
GLD icon
73
PUT
SPDR Gold Trust
GLD
$131B
– –
-17,500
Closed -$2.59M
GM icon
74
General Motors
GM
$80.4B
– –
-30,000
Closed -$623K
HYG icon
75
CALL
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$15.9B
– –
-4,500
Closed -$347K
1 2
3
4

Similar funds

JIC
JRM Investment Counsel Omaha, Nebraska $375M AUM 13.43% 1-Year Est. Return
CIM
CIM Investment Management Pittsburgh, Pennsylvania $375M AUM 32.03% 1-Year Est. Return
AIM
Access Investment Management Atlanta, Georgia $376M AUM 17.2% 1-Year Est. Return
MWM
McMill Wealth Management Norfolk, Nebraska $376M AUM 14.46% 1-Year Est. Return
RCP
RIT Capital Partners London, United Kingdom $374M AUM 25.18% 1-Year Est. Return
HPM
Helix Partners Management New York $374M AUM 136.73% 1-Year Est. Return
CAG
Compass Advisory Group Melville, New York $374M AUM 14.59% 1-Year Est. Return
LWMNY
Landmark Wealth Management (New York) Melville, New York $373M AUM 12.01% 1-Year Est. Return

DCF Advisers's Q2 2020 Portfolio in Review

As of Q2 2020, DCF Advisers held 82 positions worth $179M, up 17% from $153M the previous quarter. Its ten largest holdings account for 50% of the portfolio.

DCF Advisers withdrew a net $11.5M in Q2 2020, closing 12 positions and reducing 25 holdings. Its most notable exit was Block Inc, an estimated $1.05M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 38% of assets, up from 31% a quarter earlier, followed by Technology and Communication Services.

Against the trend, DCF Advisers opened a new position in Target worth $600K.

  • DCF Advisers's largest Q2 2020 buy was Target: 5,000 shares worth $600K.
  • DCF Advisers added most to Xencor in Q2 2020, an estimated $3.26M increase.
  • DCF Advisers's biggest Q2 2020 reduction was Bristol-Myers Squibb, cutting an estimated $1.14M.
  • DCF Advisers fully exited Block Inc in Q2 2020, selling an estimated $1.05M.
  • DCF Advisers's ten largest holdings make up 50% of its $179M portfolio in Q2 2020.
  • DCF Advisers opened 15 new positions and closed 12 in Q2 2020.
  • DCF Advisers's portfolio value rose 17% quarter-over-quarter to $179M.

Based on DCF Advisers's 13F filing for Q2 2020, filed 13 Aug 2020.